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Abstract
Recent studies suggest that PML (Promyelocytic Leukemia) suppresses p53 protein degradation by in-
hibiting MDM2 protein in the nucleus [1], and regulates a number of biological functions [2]. We modeled
a PML-MDM2-p53 regulatory network by integrating p53-MDM2 autoregulatory model [3] and related
PML pathways. We found that p53 dynamics switched at various dynamical states induced by PML
which corresponds to different cellular states. Our results show clear transitions among the stabilized,
damped and sustain states under different stress conditions induced by PML in the system. These states
in p53 dynamics is the signature of existence of various cellular states and the phase transition like
behaviour of these states involve various biological significance.
Keywords: PML (Promyelocytic Leukemia), PML-MDM2-p53 network, Phase transition, Determin-
istic model.
Introduction
PML is a well known tumor suppressor nuclear protein [1]. It has a small nuclear structure and present
in almost all mammalian cells. It regulates many processes such as cell division, terminal differentiation
of myeloid precursosr cells and neural progenitor cell differentiation [4]. It also acts as a transcription
factor for many important regulatory proteins which helps in initiation of DNA damage response, DNA
repair mechanism and organization of chromatin. A number of regulatory proteins are associated with
PML such as SUMO1 (Small ubiquitin-related modifier 1), SUMO2 (Small ubiquitin-related modifier 2),
MDM2(Mouse double minute 2), Tp53(tumor protein p53), CREBBP (CREB binding protein), RARA
(retinoic acid receptor, alpha), ZFYVE9(zinc finger, FYVE domain containing 9), UBC(ubiquitin C),
DAXX(death-domain associated protein), SP100 (SP100 nuclear antigen) etc [4–7]. PML is a key protein
for generation of PML-nuclear bodies (which is also known as kremer bodies), nuclear domain 10 or PML
oncogenic domains [8]. PML is very sensitive as well as responsive to various stress like DNA damage,
viral infection, transformation, and oxidative stress etc [9]. Recent studies suggest that PML can suppress
p53 tumour suppressor protein degradation by controlling MDM2 protein in the nucleus [1].
p53 is a widely studied and an important protein in study of normal as well cancerous cells. It
controls many important regulatory pathways such as cell cycle, apoptosis, DNA repair, cell differentiation
etc [2, 10, 11]. It is responsive to the various stress like osmotic stress, oxidative stress, DNA damage
by UV and IR, chromosomal abbration, chemical exposure, hormonal variability etc. In recent research
reports various models have been proposed to shown the p53 activation through different stresses [12].
MDM2 is a oncogenic protein which acts as negative regulator of p53 protein. MDM2 protein acts as
E3 ubiquitin ligase and voluntarily interact with p53 and forms p53-MDM2 complex and this leads to
decrease in p53 concentration level within the cell [13, 14]. Several studies have been performed to show
the p53 and MDM2 interaction and control mechanism of p53-MDM2 network. Sevaral attempt are done
2to understand the mechanism to control p53 inside the cell but still there is scope to understand the p53
restoration and the molecular event associted within the system.
In the present work we designed and studied a p53-MDM2-PML integrated network by incorporating
PML to the p53-Mdm2 regulatory network. In this model PML protein interacts with both p53 as well
MDM2 protein and activates p53 and induces p53 expression within the cell which leads to increase in
p53 concentration level within the cell. Several experimental and theoretical models have been proposed
to study the PML interaction with p53-MDM2 network but still the temporal bahaviour and dynamical
states of p53 induced by PML is not fully understood. The role of noise in the system is not systematically
incorporated and investigated. We study some of these problems in this work in order to understand
how does PML interferes cellular activities via p53. Our work is organized as follows, PML induced p53-
MDM2 biochemical regulatory model and its molecular interaction is described in section 2, numerical
results are presented with discussions in section 3 and some conclusions are drawn based on the results
we obtained in section 4.
Materials and Methods
PML induced p53−Mdm2 regulatory model
p53-MDM2 autoregulatory process is considered to be a very important regulatory process since it in-
terferes most of the cellular activities both in normal as well as cancer cells [2,14]. p53 is reported to be
synthesized in cell with a rate constant k5 [3]. Mdm2 is a negative regulator of p53, and its translation
from Mdm2 mRNA is considered to be occured with a rate k1. p53 acts as transcription factor which
interacts with Mdm2 gene due to which transcription of Mdm2 gene into Mdm2 mRNA occurs with a
rate k2. The half life ofMdm2 mRNA is low which leads to the degradation of theMdm2 mRNA which
is considered to be occured with a rate constant k3. The ubiqutination of the Mdm2 protein is taken to
occur with a rate constant k4. Mdm2 interacts with p53 protein in nucleus and forms p53 Mdm2 complex
with a rate constant k7. Further, Mdm2 which act as ubiqiutin ligase which leads to the degradation of
p53 concentration in cell with a rate k6 [14]. The dissociation of the p53 Mdm2 complex is considered
to be occured with a rate k8. PML is considered as a nucleoprotein which is constantly expressed within
the nucleus and varies in system to system with rate kPML. PML is reported to interact with Mdm2 to
form PML Mdm2 complex with a rate constant k10. Furhter the degradation of Mdm2 occurs due to
its interaction with PML, and is assumed to occur with a rate constant k11. Moreover, PML changes the
structural configuration of Mdm2 so that it is not available to interact with p53 and due to which p53
concentration increases in the cell. PML also directly interacts with p53 and forms PML p53 complex
with a rate constant k13. The interaction of PML and p53 leads to the phosphorylation of p53 protein
on serine 20 [15–17]. This phosphorylation of p53 saves it from ubiquitation induced by Mdm2. Further,
the dissociation of PML p53 complex takes place with a rate constant k14. Moreover, degradation of
the PML protein due to its shorter half life is reported to be taken place with a rate consrtant k12 [9].
In Table 1, we listed molecular species associated with p53-MDM2-PML network. In Table 2, we listed
the reaction channels, their rate constant and values taken in the simulation. The biochemical reaction
network of the model is shown in Fig. 1.
Let the configurational state vector of the system we consider corresponding to state variables (molec-
ular species in Table 1) be given by x(t) = {x1, x2, ..., xn}T , where, T is the transpose of the vector and
n = 7 Based on the biochemical network shown in figure 1, we have translated the chemical reactions
3(Table 2) into a set of coupled ordinary differential equation using mass action law given by,
dx1
dt
= k5 − k7x1x2 + k8x3 − k13x1x5 + k14x7 (1)
dx2
dt
= k1x4 − k4x2 + k6x3 − k7x1x2 + k8x3 − k10x5x2 (2)
dx3
dt
= −k6x3 + k7x1x2 − k8x3 (3)
dx4
dt
= k2x1 − k3x4 (4)
dx5
dt
= kPML − k10x5x2 + k11x6 − k12x5 − k13x1x5
+k14x7 − k16x5x6 (5)
dx6
dt
= k10x5x2 − k11x6 (6)
dx7
dt
= k13x5x1 − k14x7 (7)
where, {ki} i = 1, 2, . . . ,M(M = 14) represent the sets of rate constants of the reactions listed in Table
2 and names of the molecular species listed in Table 1. We have used runge kutta 4th order algorithm
for numerically solving the set of differential equations of our system. We developed our own coding
simulation software which is written in fortran language [18].
Results and Discussion
We present our numerical results as well as discussion on the results. We also tried to relate our results
with possible biological processes arised due to PML interaction with p53-Mdm2 regulatory network.
p53−Mdm2 bio-chemical network activation
The temporal behaviour of p53 protein for different values of PML creation rate constant kPML (Fig.
2) shows different states driven by PML. The small values of kPML (〈0.0008) could not able to activate
from its stabilized state which corresponds to nearly normal state (Fig. 2 lowermost panel). However,
for slight larger values of kPML (〈0.002), p53 dynamics exhibits damped oscillation for certain range
of time (activated state) which depends on kPML and then maintains stabilized (come back to normal
condition). Further, increase in kPML elongates the time of activation, and p53 dynamics become sustain
oscillation state (∼ 0.006) showing strongest activation induced in the system. Further increased in kPML
forces the p53 dynamics to damped oscillation and then reached stabilized state at larger concentration
level (signature of apoptosis). Further, it is observed as the concentration level of PML increases which
corrosponds to the rate constant of synthesis of PML within the cell, the temporal behaviour of p53 is also
changes. This study suggests that as PML concentration increases the stress level in the cell also increases
which is suppose to be due to molecular interaction of PML with p53-Mdm2 network. Further, It is also
to be noted that as value of kPML increases from this particular range, the amplitude is also increases.
This is probably due to higher stress generated by PML, which induces the p53 activation. This indicates
that at this particular concentration of PML, the system is succumb to the stress and system is moving
towards the apoptosis(cell death). Finally, when the concentration of PML is reached to be very high i.e
at kPML=0.05, we have got steady state level of p53. This suggest that, the system is succumb to stress
and there is no further activation of p53 is observed and and cell goes for apoptosis(apoptosis) [19].
Similarly, we have analysed the temporal behaviour of Mdm2 protein as shown in Fig. 3 for same
values of kPML as in the case of p53. Similar effect is observed but correspodingly in reverse manner as
4shown in p53 temporal behaviour which is supposed to be due to the sequestering effect of PML upon
Mdm2 which is shown in Fig. 3.
A two dimensional plot of p53-Mdm2 network and its associated molecule is also shown in Fig. 4. In
the first left hand Panel in Fig 3, the quantitave measurement of p53 verses Mdm2 which shown through
correspoding configuration space for various values of kPML. These results further verify the temporal
behaviour discussed above.
Stability analysis of p53 and Mdm2
Stability analysis for the system is shown in Fig. 5 and 6. We have analysed the stability of the system by
two parameter, namely amplitude and maxima in the dynamics (p53 and Mdm2). In Fig. 5 the maxima
of p53 and Mdm2 are found to be remain stable up to certain values of kPML, then it increases with
respect to kPML values up to 0.006 and after which it decreases i.e in between kPML=0.006 to 0.008.
Further increasing kPML values become constant. This observation suggests that as PML concentration
increases within the systems, the stress upon the system increases which leads to the increase in synthesis
of p53 in the system which we can easily understand from the increase in maxima in p53 and Mdm2 and
corresponding amplitudes (Fig. 6). We can also observe the amplitude death regimes (for small and large
kPML values), and in between stress or activated regime.
Steady State Solutions for the systems
The steady state solutions of the deterministic equations given by (1)-(7) corresponding to the concen-
trations of the molecular species can be obtained by taking, d[xi]/dt = 0, where i = 1, 2, ..., N (N = 7).
Imposing these conditions we get seven differential equations involving seven variables corresponding to
concentrations of the seven molecular species. Using these equations the steady state solution for [x1],
[x1]
∗
deter can be obtained and is given below,
[x1]
∗
deter =
√
k3k4k5
k1k2k7
(
1 +
k8
k6
)
(8)
This steady state solution [x1]
∗
deter gives us the behaviour of the p53 protein concentration when it is in
extreme conditions and it is affected by various mechanisms. The equation (8) indicates that p53 level is
in fact influenced by various rate constants of various molecular species, their complex formation, decay
and creation etc. If we make the rate of formation of MDM2, k1 a variable then from this equation it is
found that [x1]
∗
deter is inversely proportional to
√
k1 indicating the inhibiting activity of MDM2 to the
steady state level of p53. The factor k8/k6 can be seen as the rate of dissociation of p53 MDM2 per p53
decay rate i.e. a factor which indicate average amount of availability of p53 and MDM2 in the system.
As k8/k6 increases more p53 and MDM2 are available in the system and vice versa.
We then solve for steady state solution of MDM2 i.e. [x2]
∗
deter as explained above and is given by,
[x2]
∗
deter =
√
k1k2k5
k3k4k7
(
1 +
k8
k6
)
(9)
Similarly, [x2]
∗
deter gives us the steady state level of MDM2 in extreme conditions and as in the case of
p53, its steady state level is affected by other rate constants. However this steady state level is directly
proportional to the
√
k5 which is the rate of p53 protein formation. This means that the MDM2 steady
state is strongly activated by p53 protein interaction in the network which is in agreement with the
experimental results reported in qualitative sense.
5Similarly, following the same procedure the steady state solutions of the variables [x3]
∗
deter and [x4]
∗
deter
are obtained by solving the steady state equations and are given by,
[x3]
∗
deter =
√
k2k4k5
k1k3k7
(
1 +
k8
k6
)
(10)
[x4]
∗
deter =
k5
k6
(11)
From equation (10) that [x3]
∗
deter ∝ 1√k1 indicating suppressing effect of MDM2 on MDM2 mRNA,
however, [x3]
∗
deter ∝
√
k5 which reveals that p53 activates MDM2 mRNA. Further, from equation (11)
we have [x4]
∗
deter ∝ k5 indicating p53 MDM2 is activated by p53. Now we solve for [x5]
∗
[x6]∗
by relating to
the rate constants of p53 and MDM2 as in the following,
[x5]
∗
deter
[x6]∗deter
=
k11
k10
√√√√ k3k4k7
k1k2k5
(
1 + k8
k6
) (12)
At constant level of [x6]
∗
deter , the inversely proportional of [x5]
∗
deter to
√
k1 gives rise the suppressing
activity of MDM2 to PML steady state level which is in agreement with the experimental results and
predictions.
Stress driven by PML and Mdm2 interaction
PML interacts with p53 and Mdm2 allowing to change the state of the system. The interaction of PML
and p53 is one important interaction which can change the fate of the system via p53. The interaction rate
of PML and Mdm2, k10 indicates the change in Mdm2 due to change in PML concentration level. The
increase in k10 allows the increase in amplitude of p53 as well as Mdm2 indicating increase in activation
in the system (Fig. 7). Further, it is also observe that as k10 increases the amplitude death regime in
small kPML regime (normal state regime) become shifted towards smaller kPML direction. It means that
increase in k10 the system is activated quicker. Similarly, the increase in k10 extends the amplitude death
regime. Surprisingly, this increase in k10 needs larger values of kPML to reach apoptosis. Same scenario
is obtained for Mdm2 case also.
Conclusion
PML protein is found to be a tumour suppresser protein and it activates many protein to acheive cellular
apoptosis. Although it directly interacts with both p53 and Mdm2, its behaviour is different for both the
proteins. In the first case it activates the expression and in second case it modified the protein properties
so that it can not negatively feedback upon previous one as reported in various experimental results.
Our results support the stabilization effect of PML upon p53 and Mdm2. Simulation results clearly
explain the temporal behaviour of the system with respect to stress driving the system to different states,
stabilized, damped and sustain oscillations.
The interaction of PML and Mdm2 enhances the activation of the system and resists the system to go
to apoptosis. Similarly, interaction of PML with other interaction partners may influence in the cellular
stress. The increase in PML level in cellular system may trigger cancer in some cases which is needed to
be investigated further.
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8Table 1 - List of molecular species
S.No. Species Name Description Notation
1. p53 Unbounded p53 protein x1
2. Mdm2 Unbounded Mdm2 protein x2
3. Mdm2 p53 Mdm2 with p53 complex x4
4. Mdm2 mRNA Mdm2 messenger mRNA x3
5. PML Unbounded PML protein x5
6. Mdm2 PML Mdm2 PML Complex x6
7. p53 PML p53 PML complex x7
Tables
9Table 2 List of chemical reaction, kinetic law and their rate constant
S.No Reaction Nameoftheprocess KineticLaw RateConstant References
1 x4
k1−→ x4 + x2 Mdm2 synthesis k1〈x4〉 4.95× 10−4sec−1 [3, 14].
2 x1
k2−→ x1 + x4 Mdm2 mRNA syn-
thesis
k2〈x1〉 1.0× 10−4sec−1 [3, 14].
3 x4
k3−→ φ Mdm2 mRNA decay k3〈x4〉 1.0× 10−4sec−1 [3, 14].
4 x2
k4−→ φ Mdm2 degradation k4〈x2〉 4.33× 10−4sec−1 [3, 14].
5 φ
k5−→ x1 p53 synthesis k5 0.078sec−1 [3, 14].
6 x3
k6−→ x2 Mdm2 p53 degrada-
tion
k6〈x3〉 8.25× 10−4sec−1 [17, 20].
7 x1 + x2
k7−→ x3 Mdm2 p53 synthesis k7〈x1〉〈x2〉 11.55× 10−4sec−1 [3].
8 x3
k8−→ x1 + x2 Mdm2 p53 dissocia-
tion
k8〈x3〉 11.55× 10−6sec−1 [3].
9 φ
kPML−→ x5 PML creation kPML 5.0× 10−3sec−1 [20].
10 x2 + x5
k10−→ x6 PML Mdm2 complex
formation
k10〈x2〉〈x5〉 2.0× 10−3sec−1 [20].
11 x6
k11−→ x5 Decreasing of Mdm2 k11〈x1〉 3.3× 10−5sec−1 [20].
12 x5
k12−→ φ PML decay k12〈x5〉 5.0× 10−1sec−1 [20].
13 x1 + x5
k13−→ x7 p53 PML complex
formation
k13〈x1〉〈x5〉 1.0× 10−6sec−1 [21, 22].
14 x7
k14−→ x1 + x5 dissociation of
p53 PML complex
k14〈x7〉 1.0× 10−6sec−1 [21, 22].
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Figure Legends
Figure 1 - PML induced p53−Mdm2 biochemical regulatory model
The schematic diagram of stress p53-Mdm2-PML model.
Figure 2a - Effect of PML on p53 protein
Temporal behaviour of p53 due to the switching of PML protein at various concentration level i.e
0.04,0.01,0.009,0.006,0.003,0.001,0.0005,0.0008.
Figure 2b - Effect of PML on Mdm2 protein
Temporal behaviour of Mdm2 due to the switching of PML protein at various concentration level i.e
0.04,0.01,0.009,0.006,0.003,0.001,0.0005,0.0008.
Figure 3 - Two dimensional recurrence plot
Two dimensional recurrence plots between (p53−Mdm2), (p53−PML), (Mdm2−PML), (p53 Mdm2−
PML), (Mdm2 mRNA− PML)for different values of rate constants k PML, i.e. 0.0005, 0.001, 0.003,
0.006, 0.009, 0.01 and 0.03 respectively.
Figure 4 - Stability Analysis
Plots for the stability analysis.In the upper panel stability of p53(in magenta) and Mdm2(in blue) is shown
in terms of variablity in amplitude with respect to time. In lower panel stability of p53(in magenta) and
Mdm2(in blue) is shown in terms of variablity in time period with respect to time.
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